Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
Go back to Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 89.94 +1.61 (1.82%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.33 | 52 Week High | $8.22 | |||
| Open | $88.94 | 52 Week Low | $3.07 | |||
| Day High | $90.97 | P/E | N/A | |||
| Day Low | $88.73 | EPS | $-1.30 | |||
| Volume | 319,932 | |||||
